Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses

Table 1

In vivo study designs.

Study	Horses number	MSC tissue source	Route of injection	MSC dosage (×10^6)	Number of injections	Reference
Tendon	4	Bone marrow	Intravenous, intra-arterial, and intralesional	25–80	4	[11]
Eye	5	Adipose tissue	Intravitreal	25 and 50	2	[Borjesson, unpublished]
IV	5	Adipose tissue	Intravenous	25	3	[1]
	5	Bone marrow	Intravenous	25	3	[1]